Company Search:
Advanced Search
Sponsored Links
Regulus Therapeutics Incorporated Company Snapshot
Regulus Therapeutics Incorporated operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Regulus Therapeutics Incorporated with three other companies in this sector in the United States: Caladrius Biosciences Inc (2015 sales of $22.49 million of which 100% was Cell Therapy), Bioanalytical Systems, Inc. ($22.70 million ), and Spark Therapeutics Inc ($22.06 million ).

Sales Analysis. Sales increased substantially in 2015: During the year ended December of 2015, sales at Regulus Therapeutics Incorporated were $20.76 million. This is an increase of 170.7% versus 2014, when the company's sales were $7.67 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Regulus Therapeutics Incorporated
  Stock Performance Chart for Regulus Therapeutics Incorporated
  Stock Data: Recent Stock Performance:
  Current Price (2/17/2017): 1.15
(Figures in U.S. Dollars)
1 Week -2.1%   13 Weeks -51.1%  
4 Weeks -58.2%   52 Weeks -85.4%  
Regulus Therapeutics Incorporated Key Data:
  Ticker: RGLS Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2015 Sales 20,759,000
(Year Ending Jan 2016).
Employees: 88
  Currency: U.S. Dollars Market Cap: 60,861,801
  Fiscal Yr Ends: December Shares Outstanding: 52,923,305
  Share Type: Common Closely Held Shares: 18,367,340
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.